Losartan + Hydrochlorothiazide

DRUG3 trials

Sponsors

Boehringer Ingelheim, RESnTEC, Institute of Research, National Medical Research Center for Therapy and Preventive Medicine

Conditions

Coronary Arterial DiseaseHypertensionPercutaneous Coronary InterventionProteinuria

Phase 3

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

CompletedNCT02183701

Boehringer IngelheimHypertension

Start: 1998-04-30Updated: 2014-07-08

Unknown Phase

Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan

Not yet recruitingNCT06491940

RESnTEC, Institute of ResearchProteinuria

Start: 2024-08-01End: 2025-07-31Target: 234Updated: 2024-07-09

Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

RecruitingNCT07683585

National Medical Research Center for Therapy and Preventive MedicineCoronary Arterial Disease, Hypertension, Percutaneous Coronary Intervention

Start: 2026-04-01End: 2026-09-01Target: 207Updated: 2026-07-06